Xiaoyan Lou

1.2k total citations
29 papers, 828 citations indexed

About

Xiaoyan Lou is a scholar working on Oncology, Molecular Biology and Electrical and Electronic Engineering. According to data from OpenAlex, Xiaoyan Lou has authored 29 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Molecular Biology and 5 papers in Electrical and Electronic Engineering. Recurrent topics in Xiaoyan Lou's work include CAR-T cell therapy research (16 papers), RNA modifications and cancer (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Xiaoyan Lou is often cited by papers focused on CAR-T cell therapy research (16 papers), RNA modifications and cancer (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Xiaoyan Lou collaborates with scholars based in China, United States and Germany. Xiaoyan Lou's co-authors include Biaoyang Lin, Wei Yu, Dasong Hua, Chengmeng Jin, Lisha Li, Liqing Kang, Lei Yu, Gregory Foltz, Xu Han and Nan Xu and has published in prestigious journals such as Blood, ACS Nano and PLoS ONE.

In The Last Decade

Xiaoyan Lou

27 papers receiving 816 citations

Peers

Countries citing papers authored by Xiaoyan Lou

Since Specialization

Citations

This map shows the geographic impact of Xiaoyan Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Lou more than expected).

Fields of papers citing papers by Xiaoyan Lou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Lou. The network helps show where Xiaoyan Lou may publish in the future.

Co-authorship network of co-authors of Xiaoyan Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Lou. A scholar is included among the top collaborators of Xiaoyan Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Lou. Xiaoyan Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dysbiosis of the Gut Microbiota and Kynurenine (Kyn) Pathway Activity as Potential Biomarkers in Patients with Major Depressive Disorder 2023 ·Nutrients ·Ping Lin, Dan Li, (unknown), Qingtian Li, Xiaokui Guo, Ke Dong, Qing Chen, Xiaoyan Lou, Zhenhua Li, Ping Li, (unknown), (unknown), Yang Sun, Jing Sun, Xunjia Cheng	27
2	Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells 2023 ·Frontiers in Immunology ·Zhenyu Wei, (unknown), (unknown), (unknown), Nan Xu, Liqing Kang, Xiaoyan Lou, Lei Yu, Weixing Feng	20
3	Investigation of CRS-associated cytokines in CAR-T therapy with meta-GNN and pathway crosstalk 2022 ·BMC Bioinformatics ·Zhenyu Wei, (unknown), Nan Xu, (unknown), (unknown), Liqing Kang, Xiaoyan Lou, Lei Yu, Weixing Feng	10
4	Feasibility study of a novel preparation strategy for anti-CD7 CAR-T cells with a recombinant anti-CD7 blocking antibody 2022 ·Molecular Therapy — Oncolytics ·(unknown), Yujie Jia, (unknown), Jingwen Tan, (unknown), Nan Xu, Liqing Kang, Minghao Li, Xiaoyan Lou, Meixia Zhou, (unknown), Jiaqi Shao, Hongjia Zhu, Zhiqiang Yan, Lei Yu	19
5	Pre-clinical efficacy of CD20-targeted chimeric antigen receptor T cells for non-Hodgkin's lymphoma 2022 ·Discover Oncology ·Hairuo Wen, Xiaoyan Lou, Zhe Qu, Chao Qin, Hua Jiang, Ying Yang, Liqing Kang, Xingchao Geng, Lei Yu, Ying Huang	2
6	Ruxolitinib reduces severe CRS response by suspending CAR-T cell function instead of damaging CAR-T cells 2022 ·Biochemical and Biophysical Research Communications ·Nan Xu, Xiaofei Yang, Shengli Xue, Jingwen Tan, Minghao Li, Jing Ye, Xiaoyan Lou, Zhou Yu, Liqing Kang, Zhiqiang Yan, Lei Yu, Suning Chen, Yi‐Ting Wang	20
7	The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients 2022 ·Scientific Reports ·(unknown), Shengli Xue, Xiaowen Tang, (unknown), Suning Chen, Yue Han, Huiying Qiu, Miao Miao, Nan Xu, Jingwen Tan, Liqing Kang, Zhou Yu, Xiaoyan Lou, Yang Xu, Jia Chen, Zhiqiang Yan, Weixing Feng, Depei Wu, Lei Yu	22
8	CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer 2022 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), (unknown), Jingwen Tan, Jing Ye, Yujie Jia, Nan Xu, Liqing Kang, Minghao Li, Xiaoyan Lou, Jinge Zhou, Yi‐Ting Wang, Zhiqiang Yan, Lei Yu	18
9	A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma 2021 ·Frontiers in Oncology ·Ying Zhang, Jiaqi Li, Xiaoyan Lou, Xiaochen Chen, Zhou Yu, Liqing Kang, Jia Chen, Jin Zhou, (unknown), Zhen Yang, Minghao Li, Nan Xu, (unknown), (unknown), Guanghua Chen, Haiping Dai, Xiaowen Tang, Lei Yu, Depei Wu, Caixia Li	35
10	Preclinical efficacy and safety evaluation of interleukin-6-knockdown CAR-T cells targeting at CD19 2021 ·Annals of Translational Medicine ·Hairuo Wen, (unknown), (unknown), Zhe Qu, Juanjuan Sun, Zhou Yu, Liqing Kang, (unknown), Xiaoyan Lou, Lei Yu, Yan Huo	6
11	Case Report: Reversible Neurotoxicity and a Clinical Response Induced by BCMA-Directed Chimeric Antigen Receptor T Cells Against Multiple Myeloma With Central Nervous System Involvement 2021 ·Frontiers in Immunology ·Ying Zhang, Changfeng Zhang, Jin Zhou, Jing‐Ren Zhang, Xiaochen Chen, Jia Chen, Pu Wang, (unknown), Xiaoyan Lou, Wei Qi, Liqing Kang, Lei Yu, Depei Wu, Caixia Li	9
12	Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes 2020 ·Experimental Hematology and Oncology ·Liqing Kang, Xiaowen Tang, Jian Zhang, Minghao Li, Nan Xu, Wei Qi, Jingwen Tan, Xiaoyan Lou, Zhou Yu, Juanjuan Sun, Zhenkun Wang, Haiping Dai, Jia Chen, (unknown), Depei Wu, Lei Yu	49
13	Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma 2020 ·Biomarker Research ·Liqing Kang, Jian Zhang, Minghao Li, Nan Xu, Wei Qi, Jingwen Tan, Xiaoyan Lou, Zhou Yu, Juanjuan Sun, Zhenkun Wang, Chengcheng Fu, Xiaowen Tang, Haiping Dai, Jia Chen, Depei Wu, Lei Yu	28
14	shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia 2019 ·Blood ·Liqing Kang, Xiaowen Tang, Nan Xu, Minghao Li, Jingwen Tan, Wei Qi, Zhou Yu, Xiaoyan Lou, Shengli Xue, Xin Li, Jian Zhang, Jia Chen, Zhenkun Wang, Caixia Li, (unknown), Depei Wu, Lei Yu	2
15	UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance 2013 ·Journal of Cancer ·Chengmeng Jin, Wei Yu, Xiaoyan Lou, Fan Zhou, Xu Han, Na Zhao, Biaoyang Lin	61
16	Deep Transcriptome Profiling of Ovarian Cancer Cells Using Next-Generation Sequencing Approach 2013 ·Methods in molecular biology ·Lisha Li, Jie Liu, Wei Yu, Xiaoyan Lou, Bingding Huang, Biaoyang Lin	3
17	Targeted Re-Sequencing Identified rs3106189 at the 5′ UTR of TAPBP and rs1052918 at the 3′ UTR of TCF3 to Be Associated with the Overall Survival of Colorectal Cancer Patients 2013 ·PLoS ONE ·Jiaofang Shao, Xiaoyan Lou, Jun Wang, Jing Zhang, Chen Chen, Dasong Hua, Fan Mo, Xu Han, Shu Zheng, Biaoyang Lin	8
18	Silencing SOX2 Induced Mesenchymal-Epithelial Transition and Its Expression Predicts Liver and Lymph Node Metastasis of CRC Patients 2012 ·PLoS ONE ·Xu Han, Xuefeng Fang, Xiaoyan Lou, Dasong Hua, Wenchao Ding, Gregory Foltz, Leroy Hood, Ying Yuan, Biaoyang Lin	128
19	Recurrent Targeted Genes of Hepatitis B Virus in the Liver Cancer Genomes Identified by a Next-Generation Sequencing–Based Approach 2012 ·PLoS Genetics ·Dong Ding, Xiaoyan Lou, Dasong Hua, Wei Yu, Lisha Li, Jun Wang, Feng Gao, Na Zhao, Guoping Ren, Lanjuan Li, Biaoyang Lin	151
20	Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell 2011 ·PLoS ONE ·Wei Yu, Chengmeng Jin, Xiaoyan Lou, Xu Han, Lisha Li, Yinghua He, Hongyu Zhang, Kelong Ma, Jingde Zhu, Li‐Hua Cheng, Biaoyang Lin	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact